Literature DB >> 27122934

Serum Paraoxonase Levels are Correlated with Impaired Aortic Functions in Patients with Chronic Kidney Disease.

Tolga H Efe1, Ahmet G Ertem2, Alpaslan Altunoglu3, Cemal Koseoglu4, Ali Erayman5, Murat Bilgin1, Özge Kurmuş4, Turgay Aslan4, Mehmet Bilge4.   

Abstract

BACKGROUND: The correlation between aortic functions and paraoxonase levels has been previously demonstrated by several earlier studies. In this study, we aimed to investigate the correlation between serum paraoxonase levels and aortic functions among patients with chronic kidney disease.
METHODS: Our study enrolled 46 chronic kidney disease patients and 45 healthy controls. From these patients, serum cholesterol, creatinine, hemoglobin, and paraoxonase-1 levels were analyzed.
RESULTS: Paraoxonase-1 levels were significantly lower in patients with chronic kidney disease compared to the controls (p < 0.001). Additionally, the extent of aortic stiffness index (%) was significantly higher in chronic kidney disease patients, but aortic strain and aortic distensibility were significantly higher in healthy controls (p < 0.001, p < 0.001, and p < 0.001, respectively). We further found that paraoxonase-1 levels were correlated with aortic stiffness index, aortic strain, and aortic distensibility (p < 0.001, p < 0.001, and p < 0.001, respectively).
CONCLUSIONS: Our study demonstrated that serum paraoxonase-1 levels were significantly correlated with impaired aortic functions. The results of this study highlight the impact of serum paraoxonase-1 activity on atherosclerosis and cardiovascular adverse events. KEY WORDS: Aortic functions; Atherosclerosis; Chronic kidney disease; Echocardiography; Paraoxonase.

Entities:  

Year:  2016        PMID: 27122934      PMCID: PMC4804944          DOI: 10.6515/acs20150429a

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  37 in total

1.  Aortic function in arterial hypertension determined by pressure-diameter relation: effects of diltiazem.

Authors:  C Stefanadis; J Dernellis; C Vlachopoulos; C Tsioufis; E Tsiamis; K Toutouzas; C Pitsavos; P Toutouzas
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

2.  Paraoxonase activity stimulation by salts is higher in chronic renal failure patients than in controls.

Authors:  T Dantoine; J Debord; J P Charmes; L Merle; C Leroux-Robert
Journal:  Nephrol Dial Transplant       Date:  1998-03       Impact factor: 5.992

3.  Serum paraoxonase activity is decreased in uremic patients.

Authors:  R Schiavon; E De Fanti; D Giavarina; S Biasioli; G Cavalcanti; G Guidi
Journal:  Clin Chim Acta       Date:  1996-03-29       Impact factor: 3.786

4.  Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients.

Authors:  J D Harnett; G M Kent; P E Barre; R Taylor; P S Parfrey
Journal:  J Am Soc Nephrol       Date:  1994-01       Impact factor: 10.121

5.  Serum paraoxonase activities in hemodialyzed uremic patients: cohort study.

Authors:  D Juretić; M Tadijanović; B Rekić; V Simeon-Rudolf; E Reiner; M Baricić
Journal:  Croat Med J       Date:  2001-04       Impact factor: 1.351

6.  Lack of association between carotid intima-media thickness and PAF-acetylhydrolase mass and activity in patients with primary hyperlipidemia.

Authors:  Dimitrios N Kiortsis; Sofia Tsouli; Evangelia S Lourida; Vasilios Xydis; Maria I Argyropoulou; Moses Elisaf; Alexandros D Tselepis
Journal:  Angiology       Date:  2005 Jul-Aug       Impact factor: 3.619

7.  Serum paraoxonase (PON1) concentration in patients undergoing hemodialysis.

Authors:  Tadashi Suehiro; Yukio Ikeda; Tomoko Shiinoki; Mari Inoue; Yoshitaka Kumon; Takashi Itahara; Kozo Hashimoto
Journal:  J Atheroscler Thromb       Date:  2002       Impact factor: 4.928

8.  Pressure-diameter relation of the human aorta. A new method of determination by the application of a special ultrasonic dimension catheter.

Authors:  C Stefanadis; C Stratos; C Vlachopoulos; S Marakas; H Boudoulas; I Kallikazaros; E Tsiamis; K Toutouzas; L Sioros; P Toutouzas
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

9.  Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

Authors:  M I Mackness; S Arrol; C Abbott; P N Durrington
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

10.  The arterial system in hypertension. A prospective view.

Authors:  M E Safar; E D Frohlich
Journal:  Hypertension       Date:  1995-07       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.